Saleh A Ba-Shammakh (Saleh Ba-Shammakh)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Combination Therapy

Randomized Controlled Trial

Newly Diagnosed

Top Venues

The Journal of dermatological treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Diala M Alshiyab, Firas A Al-Qarqaz, Saleh A Ba-Shammakh, Abdulqudos Al-Fakih, Aya Altawalbeh, Safa' M Alsheyab, Danyah Sarakbi, Jihan M Muhaidat
Comparison of the efficacy of tacrolimus 0.1% ointment vs calcipotriol/betamethasone in combination with NBUVB in treatment of vitiligo. The Journal of dermatological treatment 34 (1) (2023)
Diala M Alshiyab, Saleh A Ba-Shammakh, Abdulqudos Al-Fakih, Osama Tashman, Danyah Sarakbi, Firas A Al-Qarqaz, Jihan M Muhaidat, Ausama Atwan, Michael J Cork
Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial. The Journal of dermatological treatment 35 (1) (2023)
Diala M Alshiyab, Saleh A Ba-Shammakh, Abdulqudos Al-Fakih, Osama Tashman, Danyah Sarakbi, Firas A Al-Qarqaz, Jihan M Muhaidat, Ausama Atwan, Michael J Cork
Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial. The Journal of dermatological treatment 35 (1) (2023)
Diala M Alshiyab, Saleh A Ba-Shammakh, Abdulqudos Al-Fakih, Osama Tashman, Danyah Sarakbi, Firas A Al-Qarqaz, Jihan M Muhaidat, Ausama Atwan, Michael J Cork
Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial. The Journal of dermatological treatment 35 (1) (2023)